iSAM Funds UK Ltd Acquires New Holdings in Revvity, Inc. (NYSE:RVTY)

iSAM Funds UK Ltd acquired a new stake in shares of Revvity, Inc. (NYSE:RVTY - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 5,438 shares of the company's stock, valued at approximately $607,000.

A number of other hedge funds have also recently made changes to their positions in RVTY. Assetmark Inc. lifted its stake in Revvity by 3,700.0% in the fourth quarter. Assetmark Inc. now owns 266 shares of the company's stock valued at $30,000 after acquiring an additional 259 shares during the last quarter. Optiver Holding B.V. bought a new stake in Revvity in the fourth quarter valued at approximately $33,000. Quarry LP increased its position in shares of Revvity by 45.7% during the 4th quarter. Quarry LP now owns 303 shares of the company's stock valued at $34,000 after purchasing an additional 95 shares during the last quarter. Millstone Evans Group LLC purchased a new stake in shares of Revvity in the 4th quarter valued at about $38,000. Finally, MassMutual Private Wealth & Trust FSB grew its position in shares of Revvity by 55.9% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company's stock worth $43,000 after buying an additional 138 shares during the last quarter. Hedge funds and other institutional investors own 86.65% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on RVTY shares. UBS Group upgraded Revvity from a "neutral" rating to a "buy" rating and reduced their price target for the stock from $145.00 to $115.00 in a report on Thursday, May 1st. Robert W. Baird dropped their price objective on Revvity from $127.00 to $125.00 and set an "outperform" rating for the company in a research note on Tuesday, April 29th. The Goldman Sachs Group lowered their target price on Revvity from $140.00 to $125.00 and set a "buy" rating for the company in a report on Tuesday, April 29th. Raymond James reissued an "outperform" rating and set a $120.00 target price (down from $145.00) on shares of Revvity in a research report on Tuesday, April 29th. Finally, KeyCorp raised their price target on shares of Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Four research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Revvity presently has an average rating of "Moderate Buy" and a consensus target price of $125.64.

Revvity Stock Up 1.1%

Shares of RVTY stock opened at $94.31 on Tuesday. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. The company has a market capitalization of $11.12 billion, a price-to-earnings ratio of 42.67, a PEG ratio of 3.82 and a beta of 1.02. The company's fifty day moving average price is $98.41 and its 200-day moving average price is $110.06. Revvity, Inc. has a one year low of $88.53 and a one year high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last released its earnings results on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.05. The company had revenue of $664.76 million for the quarter, compared to the consensus estimate of $662.30 million. Revvity had a net margin of 9.81% and a return on equity of 7.68%. Revvity's revenue was up 2.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.98 EPS. Sell-side analysts expect that Revvity, Inc. will post 4.94 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Shareholders of record on Friday, July 18th will be issued a $0.07 dividend. The ex-dividend date is Friday, July 18th. This represents a $0.28 dividend on an annualized basis and a yield of 0.30%. Revvity's dividend payout ratio (DPR) is 11.91%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity, Inc. (NYSE:RVTY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.